Simple Summary Primary liver cancer, also known as Hepatocellular carcinoma (HCC), is
considered to be a major global health challenge. Due to delays in diagnosis at early …

Nonalcoholic fatty liver disease (NAFLD), a spectrum of metabolic liver disease associated
with obesity, ranges from relatively benign hepatic steatosis to nonalcoholic steatohepatitis …

Hepatocellular carcinoma (HCC), the main pathological type of liver cancer, is linked to risk
factors such as viral hepatitis, alcohol intake and non‐alcoholic fatty liver disease (NAFLD) …

Nonalcoholic steatohepatitis (NASH) is the most prevalent cause of chronic liver disease
worldwide. Macrophage-mediated inflammation plays a critical role in NASH pathogenesis; …

Nonalcoholic fatty liver disease (NAFLD) has become a surge burden worldwide due to its
high prevalence, with complicated deterioration symptoms such as liver fibrosis and cancer …

Nonalcoholic steatohepatitis (NASH) is an increasingly prevalent liver disease linked to
obesity and associated complications. Endoplasmic reticulum (ER) stress provokes …

Obesity is rapidly dispersing all around the world and is closely associated with a high risk of
metabolic diseases such as insulin resistance, dyslipidemia, and nonalcoholic fatty liver …

Hepatocellular carcinoma (HCC) presents a significant global health threat, particularly in
regions endemic to hepatitis B and C viruses, and because of the ongoing pandemic of …

Immune checkpoint blockade (ICB) therapy is an important treatment option for individuals
with cancer, but it has certain limitations. Identifying a better target that can overcome tumor …

Background and Purpose Hepatic fatty acid metabolism disorder, a key pathogenic
mechanism underlying non‐alcoholic fatty liver disease (NAFLD), is associated with the …